Buys
Open market- Shares
- Avg price
- Total value
Coleen Glessner - EVP, Quality & Ethics, and CPL at Emergent BioSolutions Inc.
Issuer-level insider activity
- Role
- EVP, Quality & Ethics, and CPL
- Issuer ticker
- EBS on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Coleen Glessner in Emergent BioSolutions Inc.
Sells
Open market- Shares
- -30,608
- Avg price
- $10.00
- Total value
- -$306,080
Net
Past year- Shares
- -30,608
- Share %
- -100%
- Total value
- -$306,080
Reported holdings for Coleen Glessner in Emergent BioSolutions Inc.
Form 4 holding
EVP, Quality & Ethics, and CPL
Emergent BioSolutions Inc.
- Security class
- Common Stock
- Shares / value
- 202,201
- Estimated value
- $1,678,268
- Report date
- 08 Jun 2026
- Price
- $8.30
- Ownership
- Direct
Form 4 holding
EVP, Quality & Ethics, and CPL
Emergent BioSolutions Inc.
- Security class
- Employee Stock Option (Right to buy)
- Shares / value
- 294,447
- Estimated value
- Report date
- 03 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
EVP, Quality & Ethics, and CPL
Emergent BioSolutions Inc.
- Security class
- Employee Stock Options (Right to Buy)
- Shares / value
- 249,613
- Estimated value
- Report date
- 06 Mar 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Coleen Glessner in Emergent BioSolutions Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.